Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 120Active not recruiting 41Recruiting 35Terminated 32Unknown 31Not yet recruiting 10Withdrawn 7Suspended 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Paclitaxel 4Specimen Handling 3Magnetic Resonance Spectroscopy 3Trastuzumab 2Taxes 2Tamoxifen 2Interleukin-2 2Fluorouracil 2Cyclophosphamide 2Anastrozole 2trastuzumab biosimilar HLX02 1tivozanib 1taletrectinib 1palbociclib 1fluzoparib 1exemestane 1eribulin 1binimetinib 1atezolizumab 1aldesleukin 1Tomography, Optical Coherence 1Testosterone Propionate 1Testosterone 1Tablets 1Receptors, Chimeric Antigen 1Radiotherapy 1PF-05280014 1Ontruzant 1Ogivri 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Anastrozole × Breast × Clear all
NCT06671912 2026-05-08

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended
1,156 enrolled
Breast

Breast Carcinoma In Situ

NCT00738777 2021-01-22

Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

The Netherlands Cancer Institute

Phase 2 Suspended
250 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡